TY - JOUR
T1 - The potential of molecular screening
AU - Ahrendt, S. A.
AU - Sidransky, D.
PY - 1999
Y1 - 1999
N2 - Impressive results have been reported for several molecular screening tests for a number of human cancers and clearly demonstrate the potential of these assays at detecting cancer. However, before the introduction of these assays into clinical use, further studies are clearly needed. A prospective comparison between conventional screening methods and the newer molecular techniques documenting improved detection rates in patients with early stage cancers is required before these assays are adapted into clinical practice. In addition, broad technical improvements in molecular detection assays and high throughput automation are necessary for eventual clinical implementation. In the not-too-distant future, surgeons may be called on to identify and eradicate clinically occult disease in patients with a positive molecular screen.
AB - Impressive results have been reported for several molecular screening tests for a number of human cancers and clearly demonstrate the potential of these assays at detecting cancer. However, before the introduction of these assays into clinical use, further studies are clearly needed. A prospective comparison between conventional screening methods and the newer molecular techniques documenting improved detection rates in patients with early stage cancers is required before these assays are adapted into clinical practice. In addition, broad technical improvements in molecular detection assays and high throughput automation are necessary for eventual clinical implementation. In the not-too-distant future, surgeons may be called on to identify and eradicate clinically occult disease in patients with a positive molecular screen.
UR - http://www.scopus.com/inward/record.url?scp=0032848416&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032848416&partnerID=8YFLogxK
U2 - 10.1016/s1055-3207(18)30180-7
DO - 10.1016/s1055-3207(18)30180-7
M3 - Review article
C2 - 10452932
AN - SCOPUS:0032848416
SN - 1055-3207
VL - 8
SP - 641
EP - 656
JO - Surgical Oncology Clinics of North America
JF - Surgical Oncology Clinics of North America
IS - 4
ER -